NCT06137417View on ClinicalTrials.gov

Role of PET/CT in Peritoneal Deposits Assessment

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

March 15, 2026

Conditions
Peritoneal Metastases
Interventions
DEVICE

PET/CT

• Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions.

All Listed Sponsors
lead

Aya Khaled Mahmoud

OTHER

NCT06137417 - Role of PET/CT in Peritoneal Deposits Assessment | Biotech Hunter | Biotech Hunter